Ken Griffin Perkinelmer Inc Put Options Transaction History

Citadel Advisors LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 15, 2024	BUY	N/A	15,300 Added 193.67%	23,200 $2.81 Million
Q4 2023 Feb 14, 2024	BUY	N/A	800 Added 11.27%	7,900 $955,000
Q3 2023 Nov 14, 2023	BUY	$115.88 - $122.81 $660,516 - $700,017	5,700 Added 407.14%	7,100 $859,000
Q2 2023 Aug 14, 2023	SELL	$0.0 - $137.11 $0 - $164,532	-1,200 Reduced 46.15%	1,400 $0
Q1 2023 May 15, 2023	SELL	$120.16 - $144.38 $925,232 - $1.11 Million	-7,700 Reduced 74.76%	2,600 $346,000

Q4 2022 Feb 14, 2023	SELL	$119.0 - $147.98 $190,400 - $236,767	-1,600 Reduced 13.45%	10,300 $1.44 Million
Q3 2022 Nov 14, 2022	BUY	$118.07 - $160.96 $814,683 - $1.11 Million	6,900 Added 138.0%	11,900 $1.43 Million

562

106M

290K

123K

Ticker PKI
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 126,224,000
Market Cap $15.3B
Description
PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detectio...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.